CRP and cancer: In NHANES 2003–2014 cycles, AA hemoglobin biomarkers were related to an increase in cancer mortality (mediated by low-grade INFLA-score), an inflammatory marker derived from CRP, white blood cell and platelet counts, and granulocyte/lymphocyte ratio (26).